Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date

Overview of attention for article published in Drug Design, Development and Therapy, November 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 1 policy document that references this research output.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.